Long-Term Folic Acid (But Not Pyridoxine) Supplementation Lowers Elevated Plasma Homocysteine Level in Chronic Renal Failure

Mineral and Electrolyte Metabolism

Volumn 22, Issue 1-3, 1996, Pages 106-109

  Chauveau, Philippe ^a   Chadefaux, Bernadette ^a   Coudé, Marie ^a   Aupetit, Joëlle ^a   Kamoun, Pierre ^a   Jungers, Paul ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Chronic renal failure; Folate supplementation; Homoeysteine; Hyperhomocysteinemia; Pyridoxine supplementation

Indexed keywords

FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; AGED; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; CREATININE; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PYRIDOXINE;

EID: 0029655771     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (20)

1. Wilcken DEL, Gupta VJ: Sulphur-containing amino acids in chronic renal failure with particular reference to homocysteine and cysteinehomocysteine mixed disulphide. Eur J Clin Invest 1979;9:301-307.
2. Wilcken DEL, Gupta VJ, Reddy SG: Accumulation of sulphur-containing amino acids including cysteine-homocysteine in patients on maintenance haemodialysis. Clin Sci 1980;58:427-430.
3. Kang SS, Wong PWK, Bidani A, Milanez S: Plasma protein-bound homocyst(e)ine in patients requiring chronic haemodialysis. Clin Sci 1983;65:335-336.
4. Wilcken DEL, Gupta VJ, Betts AK: Homocysteine in the plasma of renal transplant recipients: Effects of cofactors for methionine metabolism. Clin Sci 1981;61:743-749.
5. Chauveau P, Chadefaux B, Coudé M, Aupetit J, Hannedouche T, Kamoun P, Jungers P: Increased plasma homocysteine concentration in patients with chronic renal failure. Miner Electrolyte Metab 1992;18:196-198.
6. Jungers P, Chauveau P, Ceballos I, Bardet J, Parvy P, Hannedouche T, Kamoun P: Plasma free aminoacid alterations from early to endstage chronic renal failure. J Nephrol 1994;7:48-54.
7. Chauveau P, Chadefaux B, Coudé M, Aupetit J, Hannedouche T, Kamoun P, Jungers P: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 1993;43(suppl 41): S72-S77.
8. Ueland PM, Rsfsum H: Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease, and drug therapy. J Lab Clin Med 1989;114:473-501.
9. Harker LA, Ross R, Slichter SJ, Scott CR: Homocystine-induced arteriosclerosis: The role of endothelial cell injury and platelet response in its genesis. J Clin Invest 1976;58:731-741.
10. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J: Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993;91:308-318.
11. McCully KS: Vascular pathology of homocysteinemia: Implications for the pathogenesis of arteriosclerosis. Am J Pathol 1969;56:111-128.
12. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I: Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991;324:1149-1155.
13. Ibels LS, Stewart JH, Mahony JF, Neale FC, Sheil AGR: Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients: A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis. Q J Med 1977;46:197-214.
14. Wilcken DEL, Dudman NPB, Tyrrell PA, Robertson MR: Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: Possible implications for prevention of vascular disease. Metabolism 1988;37:697-701.
15. Chadefaux B, Coudé M, Hamet M, Aupetit J, Kamoun P: Rapid determination of total homocysteine in plasma. Clin Chem 1989;35:2002.
16. Arnadottir M, Brattstrom L, Simonsen O, Thysell H, Hultberg B, Anderson A, Nilsson-Ehle P: The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 1993;40:236-240.
17. Hultberg B, Andersen A, Sterner G: Plasma homocysteine in renal failure. Clin Nephrol 1993;40:230-234.
18. Selhub J, Jacques PF, Wilson PWF, Rush D, Rosenberg IH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270:2693-2698.
19. Swainson C, Winney R: Do dialysis patients need extrafolate? Lancet 1983;i:239.
20. Brattstrom L, Israelson B, Jeppson H, Hultberg B: Folic acid, an innocuous means of reducing plasma homocysteine. Scand J Clin Lab Invest 1988;48:215-221.